证券代码：301235 证券简称：华康洁净 公告编号：2025-144 转债代码：123251 转债简称：华医转债 武汉华康世纪洁净科技股份有限公司 关于股东减持计划期限届满的公告 公司股东阳光人寿保险股份有限公司保证向本公司提供的信息内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 武汉华康世纪洁净科技股份有限公司(以下简称"公司"）于2025年9月8日在巨 潮资讯网披露了《关于持股5%以上股东减持股份的预披露公告》（公告编号：2025- 105）。持有公司股份5,605,246股的股东阳光人寿保险股份有限公司（以下简称"阳 光人寿"）拟减持股份数量不超过3,233,017股，减持比例不超过当时公司总股本的3%。 在任意连续九十个自然日内通过集中竞价交易减持股份的总数，不超过公司股份总数 的1%；在任意连续九十个自然日内采取大宗交易方式减持的股份总数，不超过公司股 份总数的2%。（如遇派息、送股、转增股本、配股等除权除息事项，上述拟减持股份 数量将相应进行调整，但减持股份占公司总股本的比例不变；公司总股本如因可转债 转股、股份回 ...

Market Overview - The medical device sector experienced a decline of 0.74% on December 29, with Huakang Clean leading the drop [1] - The Shanghai Composite Index closed at 3965.28, up 0.04%, while the Shenzhen Component Index closed at 13537.1, down 0.49% [1] Top Performers - Meihao Medical (301363) saw a closing price of 25.04, with an increase of 8.30% and a trading volume of 197,100 shares, totaling a transaction value of 482 million yuan [1] - Mailande (688273) closed at 41.73, up 8.22%, with a trading volume of 55,200 shares and a transaction value of 227 million yuan [1] - Kangzhong Medical (688607) closed at 45.80, up 7.23%, with a trading volume of 40,200 shares and a transaction value of 180 million yuan [1] Underperformers - Huakang Clean (301235) closed at 39.21, down 8.54%, with a trading volume of 123,300 shares and a transaction value of 488 million yuan [2] - C Jianxin (688805) closed at 47.16, down 7.26%, with a trading volume of 89,000 shares and a transaction value of 426 million yuan [2] - Furuim Medical (300049) closed at 71.93, down 4.20%, with a trading volume of 66,800 shares and a transaction value of 485 million yuan [2] Capital Flow - The medical device sector saw a net outflow of 565 million yuan from institutional investors, while retail investors experienced a net inflow of 328 million yuan [2] - The overall capital flow indicates a mixed sentiment, with institutional investors pulling back while retail investors are more active [2] Individual Stock Capital Flow - Meihao Medical (301363) had a net outflow of 54.30 million yuan from institutional investors, with retail investors also showing a net outflow of 0.76 million yuan [3] - Jigaofazhan (600807) experienced a net inflow of 44.75 million yuan from institutional investors, while retail investors had a net outflow of 61.29 million yuan [3] - Kangzhong Medical (688626) saw a net inflow of 44.26 million yuan from institutional investors, with retail investors showing a slight net outflow [3]

Group 1 - The core viewpoint of the article highlights the significant advancements in the cleanroom technology sector, particularly in the semiconductor and medical fields, with Wuhan Huakang Century Clean Technology Co., Ltd. being a leading player in this industry [1][2] - The company has established a strong technical moat in the medical cleanroom sector, having won numerous contracts and completed projects for top hospitals and national laboratories, showcasing its industry leadership [1] - The demand for ultra-clean production environments in emerging industries like semiconductors and new displays is creating a new market opportunity worth trillions, prompting the company to expand its operations into electronic cleanroom engineering [1] Group 2 - The financial needs during the company's transition period are complex, requiring comprehensive solutions that align with its development pace, which led to the creation of a tailored financial service package by Industrial Bank's Wuhan branch [2] - The collaboration between the bank and the company has been efficient, with the entire process from demand matching to approval taking only one month, demonstrating the bank's commitment to supporting the company's strategic growth [2] - Huakang Medical's electronic cleanroom division has made a strong start, securing nearly 600 million yuan in orders within 10 months and aiming for a strategic target of 1 billion yuan for the year, exemplifying innovation-driven industrial upgrades [2]

Market Overview - The medical device sector increased by 1.35% on December 25, with Sainuo Medical leading the gains [1] - The Shanghai Composite Index closed at 3959.62, up 0.47%, while the Shenzhen Component Index closed at 13531.41, up 0.33% [1] Top Performers - Sainuo Medical (688108) closed at 20.43, up 14.90%, with a trading volume of 609,800 shares and a transaction value of 1.22 billion [1] - Jinhao Medical (920925) closed at 33.03, up 12.81%, with a trading volume of 38,400 shares [1] - Mailland (688273) closed at 40.38, up 12.07%, with a trading volume of 54,800 shares [1] - Tianchen Medical (688013) closed at 52.94, up 11.10%, with a trading volume of 31,200 shares [1] - Xiangyu Medical (688626) closed at 57.47, up 6.80%, with a trading volume of 53,400 shares [1] Underperformers - C Jianxin (688805) closed at 53.31, down 8.28%, with a trading volume of 142,100 shares and a transaction value of 754 million [2] - Tianyi Medical (301097) closed at 51.89, down 5.43%, with a trading volume of 18,800 shares [2] - Hualan Co. (301093) closed at 49.54, down 2.75%, with a trading volume of 39,000 shares [2] Capital Flow - The medical device sector saw a net inflow of 137 million from institutional investors, while retail investors experienced a net inflow of 65.58 million [2] - The sector's main funds saw a net outflow of 203 million from speculative funds [2] Individual Stock Capital Flow - Sainuo Medical had a net inflow of 117 million from main funds, but a net outflow of 98.09 million from retail investors [3] - Zhend Medical (603301) had a net inflow of 85.32 million from main funds, with a net outflow of 76.17 million from retail investors [3] - Huakang Clean (301235) had a net inflow of 65.37 million from main funds, with a net outflow of 64.32 million from retail investors [3]

Group 1 - The core viewpoint of the news is that Huakang Clean has seen a significant increase in its stock price, rising by 5.12% to reach 44.97 yuan per share, with a trading volume of 454 million yuan and a turnover rate of 14.54%, resulting in a total market capitalization of 4.847 billion yuan [1] - Huakang Clean, established on November 12, 2008, and listed on January 28, 2022, is located in Wuhan, Hubei Province, and specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1] - The revenue composition of Huakang Clean's main business includes: 85.24% from purification system integration, 8.53% from medical consumables sales, 3.74% from medical equipment sales, 1.88% from operation and maintenance services, and 0.61% from other sources [1] Group 2 - Among the top ten circulating shareholders of Huakang Clean, a fund under China Merchants Fund, specifically the China Merchants Quantitative Selected Stock A (001917), has entered the list in the third quarter, holding 470,000 shares, which accounts for 0.65% of the circulating shares [2] - The China Merchants Quantitative Selected Stock A fund has achieved a return of 40.19% this year, ranking 1059 out of 4197 in its category, and a return of 37.64% over the past year, ranking 1020 out of 4170 [2] - The fund manager of China Merchants Quantitative Selected Stock A is Wang Ping, who has a total tenure of 15 years and 191 days, with the fund's total asset size at 21.247 billion yuan [3]

Group 1 - Guangqi Technology's controlling shareholder proposed a share buyback of 50 million to 100 million yuan for employee stock ownership plans or equity incentives [1] - Xingyuan Zhuomai received a supplier designation from a domestic electric vehicle manufacturer to develop and supply reducer shell components, with expected sales of approximately 575 million yuan over four years from 2027 to 2030 [2] - Weigao Bio's application for clinical trials of subcutaneous human immunoglobulin has been accepted by the National Medical Products Administration, targeting primary immunodeficiency diseases [3] Group 2 - Hongda Electronics disclosed uncertainty regarding the IPO progress of its associate Jiangsu Zhanxin, in which it holds a 13.79% stake [4] - Kangchen Pharmaceutical received FDA approval to conduct clinical trials for its KC1086 project, aimed at treating advanced recurrent or metastatic solid tumors [5] - Kweichow Moutai adjusted its share buyback price ceiling to 1863.67 yuan per share, effective from December 19, 2025 [6] Group 3 - Mousse Co. announced that its controlling shareholder and actual controllers committed not to reduce their holdings within one year [7] - Tongxingbao's subsidiary signed a business contract worth 43.166 million yuan for a cloud expansion project [8] - Kaifa Electric announced plans for three shareholders to collectively reduce their holdings by 0.6999% [9] Group 4 - Longpan Technology plans to increase the production capacity of lithium iron phosphate cathode materials from 62,500 tons per year to 100,000 tons per year [10] - Zhuhai Guanyu announced plans for two shareholders to reduce their holdings by up to 3% [11] - Jiaheng Home Textiles is planning a change in control, leading to a temporary suspension of its stock [12] Group 5 - Kehua Bio's subsidiary received a medical device registration certificate for a gene polymorphism detection kit [13] - Saitex New Materials' actual controller plans to reduce holdings by up to 3% [14] - Sanhui Electric announced a shareholder's plan to reduce holdings by up to 2% [15] Group 6 - Binhua Co. plans to establish a venture capital fund with a total scale of 400 million yuan, focusing on strategic emerging industries [16] - Jindun Co. announced plans for two shareholders to reduce their holdings by up to 4% [17] - Hengdian East Magnetic's controlling shareholder plans to reduce holdings by up to 1% [18][19] Group 7 - Luxin Investment's controlling shareholder plans to reduce holdings by up to 1% [20] - Huakang Clean announced a joint bid for a hospital procurement project worth 157 million yuan [21] - Xuedilong plans to reduce its repurchased shares by up to 488,560 shares [22] Group 8 - Enhua Pharmaceutical's subsidiary signed an exclusive commercial cooperation agreement for three long-acting antipsychotic products [23] - Aier Eye Hospital plans to acquire partial equity in 39 institutions for a total of 963 million yuan [24] - Gaozheng Mining plans to acquire 100% equity of Overseas Explosives for 510 million yuan [25] Group 9 - Donghong Co. plans to repurchase shares worth 30 million to 60 million yuan for employee stock ownership plans [26] - Bear Electric's controlling shareholder plans to reduce holdings by up to 0.64% [27] - *ST Zhengping announced the initiation of pre-restructuring by the Xining Intermediate Court [28][29] Group 10 - Caesar Travel's shareholder plans to reduce holdings by up to 3% [30] - Lianchuang Electronics announced a change in controlling shareholder to Jiangxi State-owned Assets Supervision and Administration Commission [31] - Beixin Road and Bridge plans to transfer 5.33% equity in Henan Yuhang for 243 million yuan [32] Group 11 - Fenglong Co. is planning a change in control, with stock resuming trading [33]

Core Viewpoint - Huakang Clean experienced a decline of 3.26% in stock price on December 24, with a trading volume of 670 million yuan, indicating potential volatility in the stock market performance [1] Financing Summary - On December 24, Huakang Clean had a financing buy-in amount of 75.04 million yuan and a financing repayment of 78.03 million yuan, resulting in a net financing buy of -2.99 million yuan [1] - The total financing and securities balance for Huakang Clean reached 152 million yuan, accounting for 3.30% of the circulating market value, which is above the 90th percentile level over the past year, indicating a high financing level [1] - In terms of securities lending, Huakang Clean repaid 100 shares on December 24, with no shares sold, and a remaining securities lending balance of 6,900 shares valued at 295,200 yuan, also above the 90th percentile level over the past year [1] Business Performance - As of December 19, Huakang Clean had 10,700 shareholders, an increase of 3.08% from the previous period, while the average circulating shares per person decreased by 2.99% to 6,802 shares [2] - For the period from January to September 2025, Huakang Clean reported a revenue of 1.431 billion yuan, representing a year-on-year growth of 32.59%, and a net profit attributable to shareholders of 61.16 million yuan, which is a significant increase of 211.46% year-on-year [2] Dividend and Shareholding - Since its A-share listing, Huakang Clean has distributed a total of 40.02 million yuan in dividends, with 29.46 million yuan distributed over the past three years [3] - As of September 30, 2025, new institutional shareholders include Fortune Optimized Enhanced Bond A/B (100035) as the sixth largest shareholder with 1.8 million shares, and Fortune Jiuli Steady Allocation Mixed A (003877) as the ninth largest shareholder with 497,800 shares [3]

Group 1 - Shenghui Integration (603163.SH): The stock price has risen significantly in the short term, deviating from the company's fundamentals, indicating a potential risk of decline in the future [1] - Victory Energy (001331.SZ): The company does not engage in robotics-related business [1] - Aerospace Engineering (603698.SH): The company does not involve in commercial aerospace [1] Group 2 - Wankai New Materials (301216.SZ): The controlling subsidiary plans to provide lightweight components and structural parts related to humanoid robot arms and humanoid assembly services to Lingxin Qiaoshou [1] - Huakang Clean (301235.SZ): The consortium is pre-awarded the procurement project for special departments of Huian County Hospital (Phase I) [1] - Tongda Co., Ltd. (002560.SZ): Pre-awarded a 154 million yuan project from the State Grid [1] Group 3 - Aier Eye Hospital (300015.SZ): Plans to acquire partial equity in 39 institutions including Bozhou Aier and Lianyungang Aier [1] - Aucma (600336.SH): Plans to transfer 55% equity of the Information Industry Park company [1] - Donghong Co., Ltd. (603856.SH): Plans to repurchase shares with an investment of 30 million to 60 million yuan [1] Group 4 - Caesar Travel (000796.SZ): Jingu Trust plans to reduce its holdings by no more than 3% [1] - Jindun Co., Ltd. (300411.SZ): High-tech Investment and Founder Securities plan to collectively reduce their holdings by no more than 4% [1] - Hengdian East Magnetic (002056.SZ): The controlling shareholder plans to reduce its holdings by no more than 1% [1] Group 5 - Lianchuang Electronics (002036.SZ): Plans to raise no more than 1.63 billion yuan through a private placement to Jiangxi State-owned Capital Venture [1] - Xingyuan Zhuomag (301398.SZ): Received project designation notification from a client [1]

Market Overview - As of December 24, the Shanghai Composite Index closed at 3940.95 points, up by 20.97 points, representing a 0.53% increase [1] - The Shenzhen Component Index closed at 13486.42 points, up by 117.43 points, with a 0.88% increase [1] - The ChiNext Index closed at 3229.58 points, up by 24.57 points, reflecting a 0.77% increase [1] Stock Performance - A total of 89 A-shares had a turnover rate exceeding 20%, with six stocks, including C Jianxin and C Nabai Chuan, having turnover rates above 50% [1] - C Jianxin (688805) had a closing price of 58.12 yuan and a turnover rate of 77.25%, with a significant increase of 212.81% [1] - C Nabai Chuan (301667) closed at 82.73 yuan, with a turnover rate of 67.98%, but experienced a decline of 28.06% [1] - C Xihua (603248) closed at 26.01 yuan, with a turnover rate of 57.63%, and a decrease of 29.34% [1] - C Tiansu (301449) closed at 75.83 yuan, with a turnover rate of 54.69%, down by 24.93% [1] - Other notable stocks include C Youxun (688807) with a closing price of 231.60 yuan and a turnover rate of 50.23%, up by 14.03% [1] Additional Notable Stocks - Huazhong Cable (001208) closed at 21.05 yuan with a turnover rate of 49.18%, up by 6.10% [1] - Guangdao Tui (920680) closed at 1.32 yuan, with a turnover rate of 46.41%, and an increase of 29.41% [1] - Tongyu Communication (002792) closed at 34.71 yuan, with a turnover rate of 42.86%, up by 6.31% [1] - Shennong Agriculture (300189) closed at 7.90 yuan, with a turnover rate of 41.35%, up by 1.41% [1]

Group 1 - The core viewpoint of the article is that Huakang Clean (301235.SZ) has successfully participated in a bidding project for the procurement of special departments at Huian County Hospital, with a significant contract amount [1] - The project was awarded a total bid amount of 156,849,000.00 yuan, with Huakang Clean as the leading entity in the consortium [1] - The expected share for Huakang Clean from the project is 79,321,973.11 yuan, subject to the final contract terms [1]